Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33129376

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Dec
First author
Kumar SK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Dec;21(12):1547-1549. doi: 10.1016/S1470-2045(20)30587-8.
    note
    Source null
    related pmid
    33129377
    relationship
    Comment in

Authors and identifiers

  1. name
    Kumar SK
    type
    Author
  2. name
    Harrison SJ
    type
    Author
  3. name
    Cavo M
    type
    Author
  4. name
    de la Rubia J
    type
    Author
  5. name
    Popat R
    type
    Author
  6. name
    Gasparetto C
    type
    Author
  7. name
    Hungria V
    type
    Author
  8. name
    Salwender H
    type
    Author
  9. name
    Suzuki K
    type
    Author
  10. name
    Kim I
    type
    Author
  11. name
    Punnoose EA
    type
    Author
  12. name
    Hong WJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kumar SK
    type
    Author
  2. name
    Harrison SJ
    type
    Author
  3. name
    Cavo M
    type
    Author
  4. name
    de la Rubia J
    type
    Author
  5. name
    Popat R
    type
    Author
  6. name
    Gasparetto C
    type
    Author
  7. name
    Hungria V
    type
    Author
  8. name
    Salwender H
    type
    Author
  9. name
    Suzuki K
    type
    Author
  10. name
    Kim I
    type
    Author
  11. name
    Punnoose EA
    type
    Author
  12. name
    Hong WJ
    type
    Author
bibliography ids
  1. nci-bib-c6e7dc1a0ec5c16c2a72fb04
book metadata
content sha256
d3e590f5f75686e64d96f8744f3e455b56cce27425d5b041c6f4556e78092f55
document type
citation
dois
  1. 10.1016/S1470-2045(20)30525-8
electronic publication date
display
2020 Oct 29
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33129376
immutable id
pubmed:33129376@d3e590f5f75686e64d96f8744f3e455b56cce27425d5b041c6f4556e78092f55
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
12
name
The Lancet. Oncology
nlm unique id
100957246
pages
1630-1642
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Dec;21(12):1547-1549. doi: 10.1016/S1470-2045(20)30587-8.
    note
    Source null
    related pmid
    33129377
    relationship
    Comment in
outcomes validated
false
pmid
33129376
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
62f79860b58323e016fec97e9a4d2a17ef09ede934fd97ca283fbb0d8f5243d4
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Dec
precision
month
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33129376/
title
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.

Preserved source evidence · Not medical advice